ResMed Inc. (RMD): Price and Financial Metrics

ResMed Inc. (RMD): $136.29

4.83 (-3.42%)

POWR Rating

Component Grades








RMD Price/Volume Stats

Current price $136.29 52-week high $243.52
Prev. close $141.12 52-week low $136.22
Day low $136.22 Volume 1,526,700
Day high $140.33 Avg. volume 852,734
50-day MA $180.28 Dividend yield 1.34%
200-day MA $209.32 Market Cap 20.04B

RMD Stock Price Chart Interactive Chart >


  • Quality is the dimension where RMD ranks best; there it ranks ahead of 62.77% of US stocks.
  • The strongest trend for RMD is in Value, which has been heading up over the past 179 days.
  • RMD ranks lowest in Momentum; there it ranks in the 7th percentile.

RMD Stock Summary

  • With a market capitalization of $21,479,778,554, RESMED INC has a greater market value than 90.53% of US stocks.
  • Price to trailing twelve month operating cash flow for RMD is currently 30.98, higher than 87.05% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 72.19%, RESMED INC's debt growth rate surpasses 87.36% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to RESMED INC are HOLX, LOGI, NYT, ICAD, and HZNP.
  • Visit RMD's SEC page to see the company's official filings. To visit the company's web site, go to

RMD Valuation Summary

  • In comparison to the median Healthcare stock, RMD's price/sales ratio is 27.5% higher, now standing at 5.1.
  • RMD's EV/EBIT ratio has moved down 1.9 over the prior 243 months.

Below are key valuation metrics over time for RMD.

Stock Date P/S P/B P/E EV/EBIT
RMD 2023-09-18 5.1 5.2 23.9 19.9
RMD 2023-09-15 5.1 5.2 23.8 19.8
RMD 2023-09-14 5.1 5.3 24.2 20.1
RMD 2023-09-13 5.1 5.2 24.0 19.9
RMD 2023-09-12 5.2 5.3 24.4 20.2
RMD 2023-09-11 5.3 5.4 24.8 20.6

RMD Growth Metrics

    The 4 year net income to common stockholders growth rate now stands at 53.62%.
  • The 4 year price growth rate now stands at 133.96%.
  • Its year over year cash and equivalents growth rate is now at -12.52%.
Over the past 52 months, RMD's revenue has gone up $1,358,459,000.

The table below shows RMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 3,763.275 370.223 809.465
2022-09-30 3,624.405 461.466 786.302
2022-06-30 3,578.127 351.147 779.437
2022-03-31 3,539.492 498.186 779.476
2021-12-31 3,443.759 577.025 521.983
2021-09-30 3,348.896 527.062 499.746

RMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RMD has a Quality Grade of C, ranking ahead of 68.39% of graded US stocks.
  • RMD's asset turnover comes in at 0.72 -- ranking 50th of 186 Medical Equipment stocks.
  • PEYE, MMSI, and SIEN are the stocks whose asset turnover ratios are most correlated with RMD.

The table below shows RMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.720 0.569 0.426
2021-06-30 0.691 0.575 0.410
2021-03-31 0.673 0.582 0.379
2020-12-31 0.676 0.582 0.342
2020-09-30 0.670 0.583 0.321
2020-06-30 0.672 0.581 0.300

RMD Price Target

For more insight on analysts targets of RMD, see our RMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $261.67 Average Broker Recommendation 1.91 (Hold)

ResMed Inc. (RMD) Company Bio

ResMed is a San DiegoCalifornia-based medical device company. It primarily provides cloud-connectable CPAP devices and masks for the treatment of sleep apnea, as well as devices and masks for treating chronic obstructive pulmonary disease (COPD), neuromuscular disease, and other respiratory-related conditions. It also provides a self-monitoring digital sensor and app for people who use inhalers to treat COPD or asthma via Propeller Health, which ResMed acquired in 2019. (Source:Wikipedia)  

RMD Latest News Stream

Event/Time News Detail
Loading, please wait...

RMD Latest Social Stream

Loading social stream, please wait...

View Full RMD Social Stream

Latest RMD News From Around the Web

Below are the latest news stories about RESMED INC that investors may wish to consider to help them evaluate RMD as an investment opportunity.

3 Top Growth Stock Picks Trading at a Massive Bargain

These growth stock picks are trading at bargain prices and are well-positioned to rebound and deliver substantial gains in the coming months.

Omor Ibne Ehsan on InvestorPlace | September 13, 2023

ResMed Inc.'s (NYSE:RMD) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

ResMed (NYSE:RMD) has had a rough three months with its share price down 31%. However, a closer look at its sound...

Yahoo | September 13, 2023

ResMed (RMD): An Uncovered Gem? Unveiling Its True Value

Is ResMed (RMD) significantly undervalued? Our comprehensive analysis dives into its intrinsic value, financial strength, profitability, and growth prospects.

Yahoo | September 11, 2023

ResMed Inc (RMD): A Deep Dive into Financial Metrics and Competitive Strengths

Unpacking the Growth and Competitive Edges of ResMed Inc (RMD)

Yahoo | September 11, 2023

Health Care Roundup: Market Talk

Gain insight on Gilead Sciences’ growth, Malaysian glove makers, and more in the latest Market Talks covering the Health Care sector.

Yahoo | September 8, 2023

Read More 'RMD' Stories Here

RMD Price Returns

1-mo -15.87%
3-mo -36.52%
6-mo -35.60%
1-year -35.67%
3-year -19.03%
5-year 25.39%
YTD -34.09%
2022 -19.47%
2021 23.41%
2020 38.33%
2019 37.85%
2018 36.38%

RMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!